These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 32993693)
1. Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia. Kiros M; Alemayehu DH; Geberekidan E; Mihret A; Maier M; Abegaz WE; Mulu A Retrovirology; 2020 Sep; 17(1):33. PubMed ID: 32993693 [TBL] [Abstract][Full Text] [Related]
2. Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia. Mulu A; Lange T; Liebert UG; Maier M BMC Infect Dis; 2014 Mar; 14():158. PubMed ID: 24655349 [TBL] [Abstract][Full Text] [Related]
3. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon. Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778 [TBL] [Abstract][Full Text] [Related]
4. Trends in HIV-1 pretreatment drug resistance and HIV-1 variant dynamics among antiretroviral therapy-naive Ethiopians from 2003 to 2018: a pooled sequence analysis. Kiros M; Biset S; Gebremariam B; Yalew GT; Abegaz WE; Geteneh A Virol J; 2023 Oct; 20(1):243. PubMed ID: 37880705 [TBL] [Abstract][Full Text] [Related]
5. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study. Mulu A; Maier M; Liebert UG PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902 [TBL] [Abstract][Full Text] [Related]
6. HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals. Bokharaei-Salim F; Esghaei M; Khanaliha K; Kalantari S; Marjani A; Fakhim A; Keyvani H PLoS One; 2020; 15(3):e0229275. PubMed ID: 32119691 [TBL] [Abstract][Full Text] [Related]
7. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China. Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560 [TBL] [Abstract][Full Text] [Related]
8. Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon. Meriki HD; Tufon KA; Anong DN; Atanga PN; Anyangwe IA; Cho-Ngwa F; Nkuo-Akenji T PLoS One; 2019; 14(11):e0225575. PubMed ID: 31751428 [TBL] [Abstract][Full Text] [Related]
9. Limited increase in primary HIV-1C drug resistance mutations in treatment naïve individuals in Ethiopia. Huruy K; Maier M; Mulu A; Liebert UG J Med Virol; 2015 Jun; 87(6):978-84. PubMed ID: 25649964 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-naïve adult patients in Luanda, Angola. Sebastião CS; Abecasis AB; Jandondo D; Sebastião JMK; Vigário J; Comandante F; Pingarilho M; Pocongo B; Cassinela E; Gonçalves F; Gomes P; Giovanetti M; Francisco NM; Sacomboio E; Brito M; Neto de Vasconcelos J; Morais J; Pimentel V Sci Rep; 2024 Jul; 14(1):15893. PubMed ID: 38987263 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone. Yendewa GA; Sahr F; Lakoh S; Ruiz M; Patiño L; Tabernilla A; Deen GF; Sesay M; Salata RA; Poveda E J Antimicrob Chemother; 2019 Jul; 74(7):2024-2029. PubMed ID: 30989237 [TBL] [Abstract][Full Text] [Related]
12. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran. Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088 [TBL] [Abstract][Full Text] [Related]
13. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya. Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281 [TBL] [Abstract][Full Text] [Related]
14. Low level of HIV-1C integrase strand transfer inhibitor resistance mutations among recently diagnosed ART-naive Ethiopians. Kiros M; Tefera DA; Andualem H; Geteneh A; Tesfaye A; Woldemichael TS; Kidane E; Alemayehu DH; Maier M; Mihret A; Abegaz WE; Mulu A Sci Rep; 2023 Apr; 13(1):6546. PubMed ID: 37085698 [TBL] [Abstract][Full Text] [Related]
15. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF; Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367 [TBL] [Abstract][Full Text] [Related]
16. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain. de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A; J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838 [TBL] [Abstract][Full Text] [Related]
17. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India. Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504 [TBL] [Abstract][Full Text] [Related]
18. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017. Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries. Kirichenko A; Kireev D; Lopatukhin A; Murzakova A; Lapovok I; Saleeva D; Ladnaya N; Gadirova A; Ibrahimova S; Safarova A; Grigoryan T; Petrosyan A; Sarhatyan T; Gasich E; Bunas A; Glinskaya I; Yurovsky P; Nurov R; Soliev A; Ismatova L; Musabaev E; Kazakova E; Rakhimova V; Pokrovsky V PLoS One; 2022; 17(1):e0257731. PubMed ID: 35061671 [TBL] [Abstract][Full Text] [Related]
20. HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru. Trebelcock WL; Lama JR; Duerr A; Sanchez H; Cabello R; Gilada T; Segura P; Reisner SL; Mayer KH; Mullins J; Bender Ignacio RA J Int AIDS Soc; 2019 Nov; 22(11):e25411. PubMed ID: 31773888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]